bf/NASDAQ:RLMD_icon.png

COM:RELMADA

Relmada Therapeutics, Inc.

  • Stock

Last Close

2.85

21/11 21:00

Market Cap

128.54M

Beta: -

Volume Today

250.57K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-20.80M
-
-2.97M
85.70%
-6.29M
111.33%
-8.96M
42.54%
-17.32M
93.26%
-59.46M
243.32%
-125.75M
111.50%
-157.04M
24.88%
-98.79M
37.09%
depreciation and amortization
9.26K
-
54.82K
492.25%
85.27K
55.55%
2.63K
96.92%
4.87K
85.38%
3.75K
22.96%
1.26K
66.47%
deferred income tax
3.71M
-
-13.31M
458.82%
-620.25K
95.34%
708.90K
214.29%
3.83M
440.15%
stock based compensation
796.95K
-
1.21M
51.47%
704.45K
41.64%
518.00K
26.47%
1.21M
134.36%
20.78M
1,611.48%
40.49M
94.90%
44.19M
9.14%
43.81M
0.87%
change in working capital
-1.12M
-
1.68M
249.81%
-247.69K
114.76%
700.06K
382.63%
1.51M
115.05%
10.85M
620.68%
-7.86M
172.49%
10.59M
234.69%
3.08M
70.92%
accounts receivables
512.43K
-
inventory
accounts payables
89.19K
-
424.43K
375.88%
-730.15K
272.03%
157.39K
121.56%
158.92K
0.97%
7.82M
4,823.11%
2.85M
63.62%
421.04K
85.21%
-1.76M
517.05%
other working capital
-1.21M
-
1.25M
203.66%
482.46K
61.51%
542.67K
12.48%
1.35M
148.14%
3.03M
124.71%
-10.71M
453.98%
10.17M
194.97%
4.32M
57.49%
other non cash items
4.89M
-
-13.11M
368.04%
-721.84K
94.49%
1.74M
340.78%
4.10M
135.65%
16.95K
99.59%
1.25M
7,260.99%
-1.55M
223.92%
241.16K
115.60%
net cash provided by operating activities
-16.23M
-
-13.14M
19.00%
-6.47M
50.80%
-6.00M
7.18%
-10.50M
74.90%
-27.81M
164.90%
-91.87M
230.38%
-103.80M
12.98%
-51.66M
50.23%
investments in property plant and equipment
-23.33K
-
-562.26K
2,310.43%
-49.69K
91.16%
-12.39K
75.06%
acquisitions net
purchases of investments
-182.05M
-
-222.98M
22.48%
-47.29M
78.79%
-90.46M
91.28%
sales maturities of investments
147.60M
-
168.86M
14.40%
67.03M
60.31%
140.92M
110.24%
other investing activites
net cash used for investing activites
-23.33K
-
-562.26K
2,310.43%
-49.69K
91.16%
-12.39K
75.06%
-34.45M
-
-54.12M
57.10%
19.73M
136.46%
50.45M
155.67%
debt repayment
-293.63K
-
-263.75K
10.17%
-273.67K
3.76%
-285.17K
-
-110.25K
61.34%
common stock issued
17.76M
-
20.53M
15.58%
185.31M
802.76%
43.43M
76.56%
common stock repurchased
dividends paid
other financing activites
13.45M
-
8.06M
-
2.63M
67.38%
1.59M
39.57%
-98.46K
106.20%
net cash used provided by financing activities
13.16M
-
-263.75K
102.00%
-273.67K
3.76%
6.54M
2,490.80%
17.48M
167.09%
28.47M
62.93%
187.94M
560.05%
45.02M
76.05%
-98.46K
100.22%
effect of forex changes on cash
net change in cash
-3.09M
-
-13.97M
351.45%
-6.79M
51.40%
528.43K
107.78%
6.98M
1,220.44%
-33.78M
584.16%
41.95M
224.17%
-39.05M
193.09%
-1.30M
96.66%
cash at beginning of period
25.56M
-
22.47M
12.10%
8.50M
62.17%
1.71M
79.88%
2.24M
30.89%
36.28M
1,520.34%
2.50M
93.12%
44.44M
1,681.02%
5.40M
87.86%
cash at end of period
22.47M
-
8.50M
62.17%
1.71M
79.88%
2.24M
30.89%
9.22M
311.65%
2.50M
72.92%
44.44M
1,681.02%
5.40M
87.86%
4.09M
24.17%
operating cash flow
-16.23M
-
-13.14M
19.00%
-6.47M
50.80%
-6.00M
7.18%
-10.50M
74.90%
-27.81M
164.90%
-91.87M
230.38%
-103.80M
12.98%
-51.66M
50.23%
capital expenditure
-23.33K
-
-562.26K
2,310.43%
-49.69K
91.16%
-12.39K
75.06%
free cash flow
-16.25M
-
-13.71M
15.66%
-6.52M
52.46%
-6.01M
7.70%
-10.50M
74.54%
-27.81M
164.90%
-91.87M
230.38%
-103.80M
12.98%
-51.66M
50.23%

All numbers in (except ratios and percentages)